Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers. 1982

P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin

The effects of nitroglycerin, infused intravenously at 3.4 and 7.5 micrograms/min over 30 min, on haemodynamic parameters were determined in the morning and the afternoon in a randomized, placebo-controlled study in 5 healthy volunteers. The mean steady-state concentrations of nitroglycerin reached in the plasma during the infusions of 3.4 and 7.5 micrograms/min were 0.35 +/- 0.06 ng/ml and 0.64 +/- 0.22 ng/ml, respectively. Wide inter-individual variation was noted. The nitroglycerin-induced increase in the orthostatic rise in heart rate and the change in digital-pulse-wave morphology roughly paralleled the plasma concentration, whereas the reduction in systolic blood pressure in the upright position was still evident 15 mins after the infusion, i.e. when nitroglycerin was no longer measurable in plasma. No significant diurnal variation in vascular sensitivity to the vasodilative action of nitroglycerin was demonstrable. The change in pulse-wave morphology resulting from the reduction in peripheral resistance (shift of the dicrotic wave in the descending limb towards the base-line) proved to be the most sensitive haemodynamic parameter.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
October 2017, Journal of critical care,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
September 1992, Critical care medicine,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
January 1993, European journal of clinical pharmacology,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
December 1994, Clinical pharmacology and therapeutics,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
May 1986, British journal of clinical pharmacology,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
July 2003, European journal of clinical pharmacology,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
January 1993, European journal of clinical pharmacology,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
January 1985, Arzneimittel-Forschung,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
April 1985, Journal of pharmacokinetics and biopharmaceutics,
P R Imhof, and A Sieber, and J Hodler, and P Müller, and B Ott, and P Fankhauser, and L C Chu, and A Gérardin
March 1999, European journal of clinical pharmacology,
Copied contents to your clipboard!